UK markets closed

Fresenius Medical Care AG & Co. KGaA (FMCQF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
31.00-0.19 (-0.63%)
At close: 10:22AM EST

Fresenius Medical Care AG & Co. KGaA

Else-KrOener Strasse 1
Bad Homburg 61352
Germany
49 6172 608 2522
https://www.freseniusmedicalcare.com

Sector(s)Healthcare
IndustryMedical Care Facilities
Full-time employees122,758

Key executives

NameTitlePayExercisedYear born
Mr. Robert Maurice Powell Jr.Chairman of the Management Board3.59MN/A1955
Ms. Helen GizaDeputy CEO, Chief Transformation Officer, CFO & Member of Mgmt Board of Fresenius Med. Care Mgmt AG1.85MN/A1968
Dr. Franklin W. Maddux F.A.C.P.Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG1.65MN/A1957
Mr. William J. ValleManagement Board Member for Care Delivery of Fresenius Medical Care Management AG4.09MN/A1960
Dr. Katarzyna Mazur-Hofsab Ph.D.Management Board Member for Care Enablement of Fresenius Medical Care Management AG4.55MN/A1963
Mr. Roberto FusteExec. Advisor for Regional StrategyN/AN/A1952
Dr. Carla KriwetCEO & Chair of the Management Board of Fresenius Medical CareN/AN/A1971
Dr. Nwamaka Eneanya M.D.Head of Strategy & OperationsN/AN/AN/A
Dr. Dominik HegerExec. VP and Head of Investor Relations, Strategic Devel. & CommunicationsN/AN/AN/A
Mr. Borries Von MullerSr. VP of Global HR Employee CommunicationsN/AN/A1961
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Corporate governance

Fresenius Medical Care AG & Co. KGaA’s ISS governance QualityScore as of 28 November 2022 is 3. The pillar scores are Audit: 1; Board: 6; Shareholder rights: 1; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.